Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Dec;113(12):1459-64.
doi: 10.1111/j.1471-0528.2006.01105.x.

A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour

S W Leung  1 , P S Ng, W Y Wong, T H Cheung
Affiliations
Randomized Controlled Trial

A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour

S W Leung et al. BJOG. 2006 Dec.

Abstract

Objective: Syntometrine is an effective uterotonic agent used in preventing primary postpartum haemorrhage but has adverse effects including nausea, vomiting, hypertension and coronary artery spasm. Carbetocin is a newly developed long-acting oxytocin analogue that might be used as an uterotonic agent. We compare the efficacy and safety of intramuscular (IM) carbetocin with IM syntometrine in preventing primary postpartum haemorrhage.

Design: Prospective, double-blinded, randomised controlled trial.

Setting: Delivery suite of a university-based obstetrics unit.

Population: Women with singleton pregnancy achieving vaginal delivery after and throughout 34 weeks.

Methods: Three hundred and twenty-nine eligible women were randomised to receive either a single dose of 100 microgram IM carbetocin or 1 ml IM syntometrine (a mixture of 5 iu oxytocin and 0.5 mg ergometrine) at the end of second stage of labour.

Main outcome measures: Difference in haemoglobin drop measured 2 days after delivery between the two groups.

Results: There was no difference in the drop of haemoglobin concentration within the first 48 hours between the two groups. The incidence of additional oxytocic injections, postpartum haemorrhage (blood loss > or = 500 ml) and retained placenta were also similar. The use of carbetocin was associated with significant lower incidence of nausea (relative risk [RR] 0.18, 95% confidence interval [CI] 0.04-0.78), vomiting (RR 0.1, 95% CI 0.01-0.74), hypertension 30 minutes (0 versus 8 cases, P < 0.01) and 60 minutes (0 versus 6 cases, P < 0.05) after delivery but a higher incidence of maternal tachycardia (RR 1.68, 95% CI 1.03-3.57).

Conclusions: IM carbetocin is as effective as IM syntometrine in preventing primary postpartum haemorrhage after vaginal delivery. It is less likely to induce hypertension and has a low incidence of adverse effect. It should be considered as a good alternative to conventional uterotonic agents used in managing the third stage of labour.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A flow chart of inclusion, exclusion and randomisation of women. PPH, postpartum haemorrhage; *8.00 to 12.00 hours of each working day.
See this image and copyright information in PMC

References

    1. Li XF, Fortney JA, Kotelchuck M, Glover LH. The postpartum period: the key to maternal mortality. Int J Gynecol Obstet. 1996;54:1–10. - PubMed
    1. Walder J. Misoprostol: preventing postpartum haemorrhage. Mod Midwife. 1997;9:23–7. - PubMed
    1. Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1988;95:3–16. - PubMed
    1. Prendiville WJ, Elbourne D, McDonald S. The Cochrane Library. Oxford, UK: Update Software; 2003. Active versus expectant management in the third stage of labour (Cochrane Review) - PubMed
    1. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004 Art. No.: CD00021. - PMC - PubMed

Publication types